Fibrinogem Ales: A homozygous case of dysfibrinogenemia (γ-Asp330 → Val) characterized by a defective fibrin polymerization site 'a'

Blood

Volumn 96, Issue 10, 2000, Pages 3473-3479

  Lounes, K C ^a   Soria, C ^a   Mirshahi, S S ^a   Desvignes, P ^a   Mirshahi, M ^a   Bertrand, O ^a   Bonnet, P ^a   Koopman, J ^a   Soria, J ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BATROXOBIN; FIBRINOGEN; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; HEMOGLOBIN GAMMA CHAIN; FIBRIN; FIBRINOGEN ALES; FIBRINOGEN VARIANT; FIBRINOLYTIC AGENT; HEMOSTATIC AGENT; PLASMIN; PROTEIN SUBUNIT; THROMBIN;

AMINO ACID SUBSTITUTION; ARTICLE; DNA DETERMINATION; DYSFIBRINOGENEMIA; EXON; FIBRIN POLYMERIZATION; HOMOZYGOSITY; HUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; THROMBIN TIME; ADULT; AFIBRINOGENEMIA; BINDING SITE; BLOOD; BLOOD CLOTTING DISORDER; CASE REPORT; CEREBROVASCULAR ACCIDENT; DRUG EFFECT; GENETICS; HOMOZYGOTE; MALE; METABOLISM; MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; THROMBOPHILIA; THROMBOSIS; ULTRASTRUCTURE;

ADULT; AFIBRINOGENEMIA; AMINO ACID SUBSTITUTION; BINDING SITES; BLOOD COAGULATION DISORDERS; CEREBROVASCULAR ACCIDENT; COAGULATION PROTEIN DISORDERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBRIN; FIBRINOGENS, ABNORMAL; FIBRINOLYTIC AGENTS; HEMOSTATICS; HOMOZYGOTE; HUMANS; MALE; MUTATION; PLASMIN; PROTEIN BINDING; PROTEIN SUBUNITS; THROMBIN; THROMBIN TIME; THROMBOPHILIA; THROMBOSIS;

EID: 0034668384     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.10.3473     Document Type: Article

References (51)

1. A two-step fibrinogen-fibrin transition in blood coagulation
2. Evidence for four different polymerization sites involved in human fibrin formation
3. Localization of a fibrin polymerization site complementary to Gly-His-Arg sequence
4. Fibrinopeptide B in fibrin assembly and metabolism: Physiologic significance in delayed release of the peptide
5. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots
6. Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin
7. Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations: Role of platelet factor XIII
8. Gamma-chain dysfibrinogenemias: Molecular structure-function relationships of naturally occurring mutations in the gamma chain of human fibrinogen
9. Platelet activation detected by turbidometric shape-change analysis: Differential influence of cytochalasin B and prostaglandin E1
10. Gerinnungsphysiologishe schnellmethode zur bestimmung des fibrinogens
11. Immunochemical quantitation of antigens by single radial immunodiffusion
12. Direct determination of plasma fibrinogen levels by heat precipitation: A comparison of the technique against thrombin clottable fibrinogen with spectrophotometry and radial immuno-diffusion
13. Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology
14. Familial dysfibrinogenemia and thrombophilia: Report on a study of the SSC Subcommittee on Fibrinogen
15. Mutation in blood coagulation factor V associated with resistance to activated protein C
16. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
17. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal
18. Purification of human and bovine fibrinogen
19. The reliability of molecular weight determinations by dodecyl sulfate-poly-acrylamide gel electrophoresis
20. Etudes des phenomenes de coagulation et de fibrinolyse par une methode simple d'enregistrement optique
21. Fibrinogen-fibrin interaction
22. Analysis of human fibrinopeptides by high-performance liquid chromatography
23. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin
24. Protective effect of calcium in the plasmin degradation of fibrinogen and fibrin fragments D
25. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
26. Separation and estimation split 'products' of fibrinogen and fibrin in human serum
27. Attachment of lymphoid cells to glutaraldehyde activated plasmatic cup: A convenient mean for quantitative estimation of cytoplasmic and membrane Ig
28. A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody
29. Solid-phase enzyme-immunoassay for detection of hepatitis B surface antigen
30. Nucleotide sequence of the gene for the gamma chain of human fibrinogen
31. A computer thrombin decay processes
32. Characterization of peptides cleaved by plasmin from the C-terminal polymerization domain of human fibrinogen
33. Fibrinogen Bastia (γ318→Tyr): A novel abnormal fibrinogen characterized by defective fibrin polymerization
34. Interaction of the fibrinogen-binding tetrapeptide Gly-Pro-Arg-Pro with fine clots and oligomers of alphafibrin: Comparisons with alpha beta-fibrin
35. Characterization of fibrinogen Milano I: Amino acid exchange gamma 330 Asp→Val impairs fibrin polymerization
36. Fibrinogen Kyoto III: A congenital dysfibrinogen with a gamma aspartic acid-330 to tyrosine substitution manifesting impaired fibrin monomer polymerization
37. Organization of the rat gamma-fibrinogen gene: Alternative mRNA splice patterns produce the gamma A and gamma B (gamma ') chains of fibrinogen
38. Lamprey fibrinogen gamma chain: Cloning, cDNA sequencing, and general characterization
39. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin
40. The primary fibrin polymerization pocket: Three-dimensional structure of a 30-kDa C-terminal γ chain fragment complexed with the peptide Gly-Pro-Arg-Pro
41. Study of 10 cases of congenital dysfibrinogenemia: Clinical and molecular aspects
42. The consumption of antithrombin III during coagulation, its consequences for the calculation of prothrombinase activity and the standardisation of heparin activity
43. Late-fibrin(ogen) fragment E modulates human alpha-thrombin specificity
44. Thrombin interaction with platelet glycoprotein Ib: Effect of glycocalicin on thrombin specificity
45. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors
46. Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin
47. Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia: Homozygous substitution of B beta 68 Ala→Thr
48. A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen)
49. Lipoprotein (a) and apolipoprotein E epsilon 4 as independent risk factors for ischemic stroke